Dear all, CRUK Combinations Alliance are pleased to announce that a new agent from Astex Pharmaceuticals is on offer to […]

NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in […]

It is a great honour to have been invited to take on the Chair of the NCRI NET sub-group. Under […]

With the support of a one year pilot grant from NETRF, Tim Meyer established a collaborative group at UCL to […]

A scientific collaboration between UCL, Dana-Farber Cancer Institute, UCSF Medical Centre and the UCL Cancer Institute / Royal Free Hospital […]

The UKINETs Research Committee are currently setting up a Neuroendocrine tumour domain of the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIPs […]

The UKINETs Research Committee are in the process of putting together an application to set up a Neuroendocrine tumour domain as […]

This project was completed by Katy Odonnell , Ron Basuroy and John Ramage following a grant from NET Patient Foundation. […]

Please share this with your networks: National NET Patient Foundation Cancer Analyst Circa £30,000 pro rata (London) Circa £27,000 pro […]

The NET Patient Foundation is seeking an analyst to work part time with Public Health England on a project to […]

Update on the NET news from ESMO in Copenhagen – the biggest congress so far attended by over 20 500 […]

NET-02:  A multi-centre, randomised, open-label, phase II trial of nanoliposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line […]